The German company reported its quarterly earnings for the first time as a public company, following the completion of its IPO on Nov. 7.
BTIG gave Centogene a Buy rating, while SVB Leerink and Evercore ISI each gave the company an Outperform rating.
Forbes reports on firms using artificial intelligence to diagnose rare genetic diseases.
PTC Therapeutics is developing a gene therapy for the rare genetic disease AADC deficiency, which impacts the production of two key neurotransmitters.
Centogene's data repository includes rare disease patient data including clinical information, health records, and a range of -omics data.
The German company offers rare disease genetic tests and services for clinical applications, as well as to support drug discovery and development programs.
The firm is looking to expand its sales internationally, as well as in the consumer-initiated market, but is being conservative with revenue growth estimates.
The Genomics Research and Innovation Network has built an open-source system for querying genotype-phenotype databases at its member hospitals.
The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.
The German company offers rare disease genetic tests and services for clinical applications and to support clients' drug discovery and development programs.
ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.
The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.
CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.
In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.